1. Anticonvulsant adverse effect monitoring - limited but prudent

   Review 09 February 2013 Pages: 2 - 2

2. Omeprazole may inhibit concurrent drug metabolism

   Review 09 February 2013 Pages: 2 - 2

3. Opinions on omeprazole and cancer

   Correspondence 09 February 2013 Pages: 2 - 2

4. Opinions on omeprazole and cancer

   Correspondence 09 February 2013 Pages: 2 - 2

5. Bayer and Hoechst set up German drug safety foundation

   Comment 09 February 2013 Pages: 3 - 3

6. Broadening the NMS diagnostic criteria

   Review 09 February 2013 Pages: 3 - 3

7. Amfebutamone

   Case report 09 February 2013 Pages: 4 - 4

8. Aminobenzoic acid

   Case report 09 February 2013 Pages: 4 - 4

9. Amiodarone

   Volunteers 09 February 2013 Pages: 4 - 4

10. Antidiarrhoeal misuse - professionals profit

    Comment 09 February 2013 Pages: 4 - 4

11. Call for distinctive vasoactive drug containers

    Comment 09 February 2013 Pages: 4 - 4

12. Amitriptyline/fluoxetine

    Case reports 09 February 2013 Pages: 5 - 5

13. Antidepressants interaction

    Clinical study 09 February 2013 Pages: 5 - 5

14. Antineoplastics

    Incidence study 09 February 2013 Pages: 5 - 5

15. Antipsychotics

    Incidence study 09 February 2013 Pages: 5 - 5

16. Aspirin

    Volunteers 09 February 2013 Pages: 5 - 5

17. BCG

    Case report 09 February 2013 Pages: 5 - 5

18. Beta blockers

    Clinical study 09 February 2013 Pages: 5 - 5

19. Ciprofloxacin

    Case report 09 February 2013 Pages: 6 - 6

20. Clozapine

    Case report 09 February 2013 Pages: 6 - 6

21. Cocaine abuse

    Incidence study 09 February 2013 Pages: 6 - 6

22. Cyclophosphamide

    Case report 09 February 2013 Pages: 6 - 6

23. Dactinomycin

    Correspondence 09 February 2013 Pages: 6 - 6

24. Desmopressin

    Case report 09 February 2013 Pages: 6 - 6

25. Digoxin overdose

    Incidence study 09 February 2013 Pages: 6 - 6

26. Erythromycin

    Case report 09 February 2013 Pages: 7 - 7

27. Fenofibrate

    Case report 09 February 2013 Pages: 7 - 7

28. Fluoxetine

    Case report 09 February 2013 Pages: 7 - 7

29. Gelatin

    Case report 09 February 2013 Pages: 7 - 7

30. Hexoprenaline

    Case report 09 February 2013 Pages: 7 - 7

31. Hydrochlorothiazide + triamterene

    Case report 09 February 2013 Pages: 7 - 7

32. Hydroxyzine

    Volunteers 09 February 2013 Pages: 7 - 7

33. Imipramine interaction

    Case report 09 February 2013 Pages: 7 - 7

34. Interferon alpha

    Case reports 09 February 2013 Pages: 8 - 8

35. Interferon alpha

    Case reports 09 February 2013 Pages: 8 - 8

36. Interferon alpha 2A/interleukin 2

    Incidence study 09 February 2013 Pages: 8 - 8

37. Iodinated glycerol

    Case report 09 February 2013 Pages: 8 - 8

38. Isoprenaline

    Incidence study 09 February 2013 Pages: 8 - 8

39. Ketoconazole

    Case report 09 February 2013 Pages: 9 - 9

40. Ketoprofen

    Case report 09 February 2013 Pages: 9 - 9

41. Lidocaine

    Case report 09 February 2013 Pages: 9 - 9

42. Megestrol

    Case report 09 February 2013 Pages: 9 - 9

43. Methotrexate

    Case report 09 February 2013 Pages: 9 - 9

44. Methotrexate interaction

    Clinical study 09 February 2013 Pages: 9 - 9

45. Methotrexate/prednisone

    Case report 09 February 2013 Pages: 9 - 9

46. Methylenedioxymetamphetamine abuse

    Case reports 09 February 2013 Pages: 10 - 10

47. Mitoxantrone + etoposide

    Incidence study 09 February 2013 Pages: 10 - 10

48. Nortriptyline

    Case report 09 February 2013 Pages: 10 - 10

49. Nortriptyline/doxepin

    Case report 09 February 2013 Pages: 10 - 10

50. Ondansetron

    Case report 09 February 2013 Pages: 10 - 10